Table 1 Individual patient characteristics and injected activity of [99mTc]Tc-N4-BTG.
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Mean | SD | |
|---|---|---|---|---|---|---|
Age [y] | 70 | 58 | 66 | 68 | 66 | 4.6 |
Weight [kg] | 84 | 102 | 85 | 80 | 88 | 8 |
Height [cm] | 170 | 186 | 172 | 172 | 175 | 6.4 |
Injected activity [MBq] | 683 | 739 | 836 | 828 | 772 | 74 |
Specific activity [MBq/kg] | 8.2 | 7.5 | 10.1 | 10.4 | 9.0 | 1.2 |
PSA [ng/ml] | 1.2 | 2.1 | 2.4 | 1.0 | 1.7 | 0.6 |
Gleason Score | 3 + 4 | 9 | 4 + 3 | 4 + 3 | ||
Initial Stage | pT2c pN0 R1 | pT3b pN1 R0 | pT2c pN1 R1 | pT2c pN0 R0 | ||
Previous treatments | RP, RTx, ADT | RP, RTx, ADT | RP, ADT | RP, RTx | ||